Pharma deviation investigation
Bring relevant quality evidence to the investigator sooner
An anonymized Indian pharmaceutical manufacturing engagement supporting a defined deviation-investigation workflow.
The investigation challenge
Quality staff had to assemble evidence from fragmented batch, laboratory, procedure and quality records. Experienced colleagues were often needed to locate comparable events. The task required reliable source references and controlled access while preserving qualified judgment.
What NeoBram delivered
The published brief describes a private retrieval assistant connected to approved records. It returned source-linked passages and comparable events for review. Document status, permissions, user roles and interaction logs formed part of the workflow. Investigators retained authority over conclusions; AI did not approve or close deviations or CAPAs.
What the engagement reported
The customer, denominators, measurement workbook and audit history are not public. Other process changes cannot be separated from these outcomes. The figures do not establish causal effect, regulatory compliance or expected results at another facility.
- 40% fewer batch deviations reported
- 55% faster CAPA closure reported
- 12 fewer investigation hours per reviewed case reported
- No post-launch audit findings stated in the brief
Scope a useful and reviewable pilot
Start with a permitted corpus and a defined investigation question. Measure evidence relevance, source correctness, review effort and total investigation time. Treat faster retrieval and changes in batch outcomes as separate measures. Quality owners should approve intended use, validation requirements and any controlled-system interaction. Deployment, content updates, support and review responsibilities need agreement before the pilot starts.
More clarity
Questions and answers
Will AI make batch-release or CAPA decisions?
Those decisions remain with authorized quality personnel under the agreed validated process.
Does a private deployment make the system compliant?
No. Suitability depends on intended use, implementation, validation, procedures and applicable requirements.
Start with one business problem